Pathological Mechanism and Targeted Drugs of COPD.

Guo, Peng; Li, Rui; Piao, Tie Hua; Wang, Chun Lan; Wu, Xiao Lu; Cai, Hong Yan

Guo, Peng; Li, Rui; Piao, Tie Hua; Wang, Chun Lan; Wu, Xiao Lu; Cai, Hong Yan.

Afiliação

Guo P; College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Changchun, 130000, People's Republic of China.
Li R; Graduate School, Beijing University of Chinese Medicine, Beijing, 100000, People's Republic of China.
Piao TH; Pulmonology Department, The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Changchun, 130000, People's Republic of China.
Wang CL; Pulmonology Department, The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Changchun, 130000, People's Republic of China.
Wu XL; Pulmonology Department, The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Changchun, 130000, People's Republic of China.
Cai HY; Pulmonology Department, The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Changchun, 130000, People's Republic of China.

Int J Chron Obstruct Pulmon Dis ; 17: 1565-1575, 2022.

Article em En | MEDLINE | ID: mdl-35855746

Assuntos

Inflamassomos; Doença Pulmonar Obstrutiva Crônica; Humanos; Inflamassomos/metabolismo; Inflamação; Interleucina-18; Interleucina-1beta/metabolismo; Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo; Doença Pulmonar Obstrutiva Crônica/diagnóstico; Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico; Doença Pulmonar Obstrutiva Crônica/metabolismo

Palavras-chave

NLRP3; chronic obstructive pulmonary disease; pathogenesis; targeted drugs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google